ArticleThe oncologist2026

Novel risk scoring system for patients with metastatic castration-resistant prostate cancer treated with lutetium-177-PSMA-617.

Margo B Gerke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.